FDA Approves Rare Pediatric Disease Product VABYSMO, Issuing Priority Review Voucher

Summary

The FDA has approved VABYSMO, a rare pediatric disease product, and is issuing a priority review voucher to its sponsor, following the required notice of approval under the FD&C Act and FDASIA.